41 results on '"Hu, Zhe-Yu"'
Search Results
2. Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody
3. AI-link omnipotent pathological robot: Bridging medical meta-universe to real-world diagnosis and therapy
4. Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial
5. Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC
6. Artificial intelligence scale-invariant feature transform algorithm-based system to improve the calculation accuracy of Ki-67 index in invasive breast cancer: a multicenter retrospective study
7. The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study
8. Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study
9. Eribulin mesylate versus eribulin plus anlotinib in patients with advanced or metastatic breast cancer: Results of a phase II study.
10. Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer
11. Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database
12. Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]
13. Correction for: Treatment strategies of hospitalized patients with coronavirus disease-19
14. Abstract PS13-17: Capecitabine maintaining treatment improves progression-free survival in metastatic breast cancer: A prospective observational study of 669 cases
15. Nomogram for Predicting Chemotherapy-Induced Nausea and Vomiting for Breast Cancer Patients
16. Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
17. Treatment strategies of hospitalized patients with coronavirus disease-19
18. Skp2 modulates proliferation, senescence and tumorigenesis of glioma
19. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis
20. PIK3CA gene mutations in the helical domain correlate with high tumor mutation burden and poor prognosis in metastatic breast carcinomas with late-line therapies
21. FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients
22. Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway
23. Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
24. ANGPTL3: a novel biomarker and promising therapeutic target
25. Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients
26. Establishment of Risk Prediction Model for Brain Metastasis with Breast Cancer by Using ctDNA Genetic Profile and Clinical Features from Real-World Data
27. Genistein Protects H9c2 Cardiomyocytes against Chemical Hypoxia-Induced Injury via Inhibition of Apoptosis
28. FGFR Aberrations Increase the Risk of Brain Metastases and Predict Drug Resistance in Metastatic Breast Cancer Patients
29. Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor
30. Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
31. Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy
32. Altered DMN functional connectivity and regional homogeneity in partial epilepsy patients: a seventy cases study
33. Abstract 2444: Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
34. Erratum to: Glycolytic genes in cancer cells are more than glucose metabolic regulators
35. Glycolytic genes in cancer cells are more than glucose metabolic regulators
36. Apogossypolone induces reactive oxygen species accumulation and controls cell cycle progression in Raji Burkkit’s lymphoma cells
37. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species
38. ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway
39. ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells
40. ApoG2, a novel inhibitor of antiapoptotic Bcl‐2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts
41. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.